Evidence map›Paper›PMID 26296571›Full record

ArticleThe Journal of general virology2015

Hepatitis C virus Genotype 1a core gene nucleotide patterns associated with hepatocellular carcinoma risk.

Brent Korba, Kirti Shetty, Alexei Medvedev, Prasanth Viswanathan, Rency Varghese, Bin Zhou, Rabindra Roy, Kepher Makambi, Habtom Ressom, Christopher A Loffredo

Open access · greenAbstract read
In one paragraph

Article in The Journal of general virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Brent KorbaDepartment of Microbiology and Immunology, Georgetown University, Washington, DC 20057, USA.
Kirti ShettyDivision of Gastroenterology & Hepatology, Johns Hopkins University, Sibley Memorial Hospital, Washington, DC 20016, USA.
Alexei MedvedevDepartment of Microbiology and Immunology, Georgetown University, Washington, DC 20057, USA.
Prasanth ViswanathanDepartment of Microbiology and Immunology, Georgetown University, Washington, DC 20057, USA.
Rency VargheseDepartment of Oncology, Georgetown University, Washington, DC 20057, USA.
Bin ZhouDepartment of Oncology, Georgetown University, Washington, DC 20057, USA.
Rabindra RoyDepartment of Oncology, Georgetown University, Washington, DC 20057, USA.
Kepher MakambiDepartment of Biostatistics, Georgetown University, Washington, DC 20057, USA.
Habtom RessomDepartment of Oncology, Georgetown University, Washington, DC 20057, USA.
Christopher A LoffredoDepartment of Biostatistics, Georgetown University, Washington, DC 20057, USA.
Georgetown University · USSibley Memorial Hospital · US

Funding

Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI STEPHEN W BYERS · 1990 to 2026
$71.5M
NCI NIH HHS P30 CA051008NCI NIH HHS P30CA051008
6 · The paper itself

Abstract

Specific sequence changes in codons 70 and 91 of the hepatitis C virus genotype 1b (HCV GT1b) core gene have been associated with increased risk of hepatocellular carcinoma (HCC). Essentially all previous studies were conducted in Asian populations with a wide range of liver disease, and none were conducted specifically in GT1a-infected individuals. We conducted a pilot study in a multiethnic population in the USA with HCV-related cirrhosis to determine if this association extended to GT1a-infected individuals and to determine if other sequence changes in the HCV core gene were associated with HCC risk. HCV core gene sequences from sera of 90 GT1 HCV carriers with cirrhosis (42 with HCC) were analysed using standard RT-PCR-based procedures. Nucleotide sequence data were compared with reference sequences available from GenBank. The frequency of sequence changes in codon 91 was not statistically different between HCC (7/19) and non-HCC (11/22) GT1b carriers. In GT1a carriers, sequence changes in codon 91 were observed less often than in GT1b carriers but were not observed in non-HCC subjects (4/23 vs 0/26, P = 0.03, Fisher's exact test). Sequence changes in codon 70 were not distributed differently between HCC and non-HCC GT1a and 1b carriers. Most importantly, for GT1a carriers, a panel of specific nucleotide changes in other codons was collectively present in all subjects with HCC, but not in any of the non-HCC patients. The utility of this test panel for early detection of HCC in GT1a-infected individuals needs to be assessed in larger populations, including longitudinal studies.

Indexed as

AdultAgedBase SequenceCarcinoma, HepatocellularCodonFemaleGenotypeHepacivirusHepatitis B Core AntigensHepatitis C, ChronicHumansLiver NeoplasmsMaleMiddle AgedMolecular Sequence DataMutationCodonHepatitis B Core Antigens

Identifiers

PMID26296571
PMCPMC4857454
OpenAlexW1884378835

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.